Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 1
1988 4
1989 1
1990 2
1991 5
1992 1
1993 3
1994 4
1995 4
1996 2
1997 7
1998 2
2000 2
2001 4
2002 2
2003 3
2004 7
2005 6
2006 8
2007 12
2008 9
2009 9
2010 7
2011 4
2012 15
2013 6
2014 3
2015 8
2016 16
2017 5
2018 7
2019 16
2020 4
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

181 results
Results by year
Filters applied: . Clear all
Page 1
[Obesity and type 2 diabetes].
Toplak H, Hoppichler F, Wascher TC, Schindler K, Ludvik B. Toplak H, et al. Among authors: ludvik b. Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S196-200. doi: 10.1007/s00508-016-0986-9. Wien Klin Wochenschr. 2016. PMID: 27052246 Review. German.
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group. Pi-Sunyer X, et al. N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892. N Engl J Med. 2015. PMID: 26132939 Free article. Clinical Trial.
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. Bakris GL, et al. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33264825
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
["Diabesity"-Obesity and type 2 diabetes (Update 2019)].
Toplak H, Leitner DR, Harreiter J, Hoppichler F, Wascher TC, Schindler K, Ludvik B. Toplak H, et al. Among authors: ludvik b. Wien Klin Wochenschr. 2019 May;131(Suppl 1):71-76. doi: 10.1007/s00508-018-1418-9. Wien Klin Wochenschr. 2019. PMID: 30980154 Review. German.
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, Ortiz RV, Wilding JPH, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group. le Roux CW, et al. Lancet. 2017 Apr 8;389(10077):1399-1409. doi: 10.1016/S0140-6736(17)30069-7. Epub 2017 Feb 23. Lancet. 2017. PMID: 28237263 Clinical Trial.
Management of Pregnant Women after Bariatric Surgery.
Harreiter J, Schindler K, Bancher-Todesca D, Göbl C, Langer F, Prager G, Gessl A, Leutner M, Ludvik B, Luger A, Kautzky-Willer A, Krebs M. Harreiter J, et al. Among authors: ludvik b. J Obes. 2018 Jun 3;2018:4587064. doi: 10.1155/2018/4587064. eCollection 2018. J Obes. 2018. PMID: 29973985 Free PMC article. Review.
Basal insulin and cardiovascular and other outcomes in dysglycemia.
ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. ORIGIN Trial Investigators, et al. N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11. N Engl J Med. 2012. PMID: 22686416 Free article. Clinical Trial.
181 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page